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ABSTRACT 
Compromised cerebral blood flow (CBF) regulation is linked to impaired functional outcome following 
concussion. Cerebral vasoreactivity (CVR), an important mechanism in CBF regulation, is the ability of 
cerebral blood vessels to alter blood flow during dynamic changes in arterial carbon-dioxide (CO₂). 
PURPOSE: The purpose of this study was to examine CVR in an ongoing prospective cohort of collegiate 
athletes during acute (day-3) and sub-acute (day-21) phases following concussion and compare them with 
non-injured athletes. METHODS: Sixteen male and female collegiate athletes (21±1 years) with sports-
related concussion and 16 sports matched non-injured controls (21±1 years) were enrolled in the study. For 
injured athletes, data was collected during the acute and sub-acute phase following concussion and for the 
controls data was collected at one time point. Symptom severity and cognition were assessed using the 
Sports Concussion Assessment Tool-3rd Edition. Continuous middle cerebral artery blood flow velocity 
(MCAV) was obtained with transcranial Doppler ultrasonography (TCD) while subjects were seated in an 
upright position. End-tidal CO₂ (PetCo₂) was measured with an infrared CO₂ analyzer attached to a nasal 
cannula. MCAV was evaluated in response to changes in PetCo₂ for 2-minutes each during normal 
breathing (normocapnia), inspiring a gas mixture containing 8% CO₂, 21% oxygen (hypercapnia) and, 
hyperventilating (hypocapnia). CVR was analyzed as the slope of the linear relationship between PetCo₂ 
and MCAV, which was expressed as the percent change in CBF velocity per mmHg change in PetCo₂. 
Independent and paired t-tests were used to compare symptom severity, and CVR between acute and sub-
acute phase following concussion with the controls. RESULTS: As anticipated, concussed athletes 
exhibited higher symptom severity (26.3±0.5 versus 5±7 P= 0.0007) and lower cognition (26.5±1.6 versus 
28.3±2.4 P=0.03) during acute phase compared to the controls. Although symptoms and cognition were 
resolved during the sub-acute phase, CVR was lower in the acute phase compared to the non-injured 
controls (1.7±0.5U versus 2.3±0.3U, P=0.0006) and it continued to be blunted in the sub-acute phase 
following concussion (1.9±0.5U P=0.04). CONCLUSION: Despite improvements in symptom and 
cognition, cerebral vasoreactivity appears to be impaired in the sub-acute phase following concussion. 
Cerebral vasoreactivity utilizing TCD may be a useful vascular biomarker for physiological recovery and 
aid in accurate return-to play decision-making. 
 
